Zdrowie i gospodarka · 03/09/1999
FDA Releases Draft Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products
The US Food and Drug Administration (FDA) has made available a draft guidance document outlining general considerations for bioavailability and bioequivalence studies for orally administered drug products, aiming to simplify the process for pharmaceutical companies and applicants
Source: Federal Register — Food and Drug AdministrationOpen original release →